Patologia Molecular y Terapéutica de las Enfermedades Aterotrombóticas e Isquémicas

Andreadou I, Schulz R, Badimon L, Adameová A, Kleinbongard P, Lecour S, Nikolaou PE, Falcão-Pires I, Vilahur G, Woudberg N, Heusch G, Ferdinandy P. Hyperlipidaemia and cardioprotection: Animal models for translational studies. BRITISH JOURNAL OF PHARMACOLOGY Dec; 177(23):5287-5311; 2020. DOI: 10.1111/bph.14931. PMID: 31769007. IF: 8,739

Andreadou I, Tsoumani M, Vilahur G, Ikonomidis I, Badimon L, Varga Z, Ferdinandy P, Schulz R. PCSK9 in Myocardial Infarction and Cardioprotection: Importance of Lipid Metabolism and Inflammation. FRONTIERS IN PHYSIOLOGY Nov 12; 11; 605497; 2020. DOI: 10.3389/fphys.2020.602497. PMID:33262707. IF: 4,566

Anguita Sanchez M., Bertomeu Martinez V., Ruiz Ortiz M., Cequier Fillat A., Roldan Rabadan I., Muniz Garcia J., Badimon Maestro L., Esteve Pastor M.A., Marin Ortuno F. (2020) Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study Anticoagulantes orales directos frente a antagonistas de la vitamina K en pacientes del «mundo real» con fibrilación auricular no valvular. Estudio FANTASIIA. REV ESP CARDIOL, 73 (1), 14-20. IF: 4,7530

Arauna D, Chiva-Blanch G, Padro T, Fuentes E, Palomo I, Badimon L. Frail older adults show a distinct plasma microvesicle profile suggesting a prothrombotic and proinflammatory phenotype. JOURNAL OF CELLULAR PHYSIOLOGY Aug 4; 236(3): 2099-2108, 2020. DOI: 10.1002/jcp.29996. PMID:32749745. IF: 6,384

Arderiu G, Lambert C, Ballesta C, Moscatiello F, Vilahur G, Badimon L. Cardiovascular Risk Factors and Differential Transcriptomic Profile of the Subcutaneous and Visceral Adipose Tissue and Their Resident Stem Cells. CELLS Oct 3; 9(10); 2235; 2020. DOI: 10.3390/cells9102235. PMID:33022994. IF: 6,277

Badimon L, Devaux Y. Transcriptomics research to improve cardiovascular healthcare. EUROPEAN HEART JOURNAL Sep 14; 41(35); 3296-3298; 2020. DOI: 10.1093/eurheartj/ehaa237. PMID:33033839. IF: 29,983

Badimon L, Luquero A, Crespo J, Peña E, Borrell-Pages M. PCSK9 and LRP5 in macrophage lipid internalization and inflammation. CARDIOVASCULAR RESEARCH. Sep 29:cvaa254. 2020. DOI: 10.1093/cvr/cvaa254. PMID:32991689. Online ahead of print. IF: 10,787

Badimon L., Suades R., Vilella-Figuerola A., Crespo J., Vilahur G., Escate R., Padro T., Chiva-Blanch G. (2020) Liquid Biopsies: Microvesicles in Cardiovascular Disease. ANTIOXID REDOX SIGN, 33 (9), 645-662. IF: 8,4010

Badimon L. ESC Advocacy: contributing to the ESC mission of reducing the burden of cardiovascular disease. CARDIOVASCULAR RESEARCH 1 Oct; 116(12):169-170; 2020. DOI: 10.1093/cvr/cvaa237. PMID:32980874. IF: 10,787

Ben-Aicha S, Badimon L, Vilahur G. Advances in HDL: much more than lipid transporters. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCE Jan 22, 21(3):732; 2020. DOI: 10.3390/ijms21030732. PMID: 31979129. IF: 5,923

Ben-Aicha S, Escate R, Casani L, Padro T, Peña E, Arderiu G, Mendieta G, Badimon L, Vilahur G. HDL lipoprotein remodelled in hypercholesterolemic blood induce epigenetically driven downregulation of endothelial HIF-1α expression in a preclinical animal model. CARDIOVASCULAR RESEARCH. June 1; 116 (7):1288-1299; 2020. DOI: 10.1093/cvr/cvz239. PMID: 31504272. IF: 10,787

Bertomeu-Gonzalez V., Moreno-Arribas J., Esteve-Pastor M.A., Roldan-Rabadan I., Muniz J., Rana-Miguez P., Ruiz-Ortiz M., Cequier A., Bertomeu-Martinez V., Badimon L., Anguita M., Lip G.Y.H., Marin F. (2020) Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry. J AM HEART ASSOC, 9 (1), e013789-. IF: 5,5010

Bertomeu-Gonzalez V, Moreno-Arribas J, Esteve-Pastor MA, Roldan-Rabadán I, Muñiz J, Otero García D, Ruiz-Ortiz M, Cequier A, Bertomeu-Martínez V, Badimon L, Anguita M, Lip GYH, Marín F; FANTASIIA Study Investigators. Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION OCT 16; E13431; 2020. DOI: 10.1111/ECI.13431. PMID:33065765 online ahead of print. IF: 4,686

Bornachea O., Benitez-Amaro A., Vea A., Nasarre L., de Gonzalo-Calvo D., Escola-Gil J.C., Cedo L., Iborra A., Martinez-Martinez L., Juarez C., Camara J.A., Espinet C., Borrell-Pages M., Badimon L., Castell J., Llorente-Cortes V. (2020) Immunization with the Gly1127-Cys1140 amino acid sequence of the LRP1 receptor reduces atherosclerosis in rabbits. Molecular, immunohistochemical and nuclear imaging studies. THERANOSTICS, 10 (7), 3263-3280. IF: 11,5560

Bugatti A, Marsico S, Mazzuca P, Schulze K, Ebensen T, Giagulli C, Peña E, Badimon L, Slevin M, Caruso A, Guzman CA, Caccuri F. Role of autophagy in von Willebrand factor secretion by endothelial cells and in the in vivo thrombin-antithrombin complex formation promoted by the HIV-1 matrix protein p17. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES Mar 16; 21(6): 1-16; 2020. DOI: 10.3390/ijms21062022. PMID: 32188077. IF: 5,923

Bugiardini R, Pavasovic S, Yoon J, van der Schaar M, Kedev S, Vavlukis M, Vasiljevic Z, Bergami M, Milicic D, Manfrini O, Cenko E, Badimon L. Aspirin for primary prevention of ST segment elevation myocardial infarction in persons with diabetes and multiple risk factors. ECLINICALMEDICINE Sep 20; 27:100548;2020. DOI:10.1016/j.eclinm.2020.100548. PMID:33150322. IF: 2,659

Bugiardini R., Yoon J., Kedev S., Stankovic G., Vasiljevic Z., Milicic D., Manfrini O., van der Schaar M., Gale C.P., Badimon L., Cenko E. (2020) Prior Beta-Blocker Therapy for Hypertension and Sex-Based Differences in Heart Failure among Patients with Incident Coronary Heart Disease. HYPERTENSION, 76 (3), 819-826. IF: 10,1900

Chiva-Blanch G, Badimon L. Benefits and Risks of Moderate Alcohol Consumption on Cardiovascular Disease: Current Findings and Controversies. NUTRIENTS Jan;12(1); 108; 2020. DOI: 10.3390/nu12010108. PMID: 31906033. IF: 5,717

Chiva-Blanch G., Sala-Vila A., Crespo J., Ros E., Estruch R., Badimon L. (2020) The Mediterranean diet decreases prothrombotic microvesicle release in asymptomatic individuals at high cardiovascular risk. CLIN NUTR, (), -. IF: 7,3240

Cordero A., Freites A., Escribano D., Bertomeu-Martinez V., Zuazola P., Badimon L. (2020) A simple score to select patients for manual thrombectomy in emergent percutaneous coronary interventions: The DDTA score. J CARDIOVASC MED, 21 (8), 595-602. IF: 2,1600

Crea F., Badimon L., Berry C., De Caterina R., Elliott P.M., Hatala R., Libby P., Linde C., Tybjaerg-Hansen A. (2020) The European heart journal: Leading the fight to reduce the global burden of cardiovascular disease. EUR HEART J, 41 (33), 3113-3116. IF: 29,9830

Damask A., Steg P.G., Schwartz G.G., Szarek M., Hagstrom E., Badimon L., Chapman M.J., Boileau C., Tsimikas S., Ginsberg H.N., Banerjee P., Manvelian G., Pordy R., Hess S., Overton J.D., Lotta L.A., Yancopoulos G.D., Abecasis G.R., Baras A., Paulding C. (2020) Patients with High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit from Alirocumab Treatment in the ODYSSEY OUTCOMES Trial. CIRCULATION, 141 (8), 624-636. IF: 29,6900

Emanueli C, Badimon L, Martelli F, Potočnjak I, Carpusca I, Robinson EL, Devaux Y. Call to action for the cardiovascular side of COVID-19. EUROPEAN HEART JOURNAL. May 14; 41(19); 1796-1797; 2020. DOI: 10.1093/eurheartj/ehaa301. PMID: 32282026. IF: 29,983

Fraser A.G., Byrne R.A., Kautzner J., Butchart E.G., Szymanski P., Leggeri I., de Boer R.A., Caiani E.G., Van de Werf F., Vardas P.E., Badimon L. (2020) Implementing the new European regulations on medical devices-clinical responsibilities for evidence-based practice: A report from the regulatory affairs committee of the European society of cardiology. EUR HEART J, 41 (27), 2589-2596. IF: 29,9830

Garcia-Fernandez A, Esteve-Pastor MA, Rabadan IR, Muñiz J, Ruiz Ortiz M, Cequier A, Bertomeu-Martínez V, Badimon L, Otero D, Lip GYH, Marín F. Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: Real-world data from the FANTASIIA registry. ANNALS OF MEDICINE. Sep; 52(6): 300-309; 2020. DOI: 10.1080/07853890.2020.1778176. PMID: 32500748. IF: 4,709

Gorog D.A., Vilahur G. (2020) Peripartum cardiomyopathy: Can the link between prolactin and PAI-1 provide a clue?. CARDIOVASC RES, 116 (11), 1791-1793. IF: 10,7870

Grigorian Shamagian L; Sanz-Ruiz R; Climent A; Badimon L; Barile L; Bolli R; Chamuleau S; Grobbee DE; Janssens S; Kastrup J; Kragten-Tabatabaie L; Madonna R; Mathur A; Menasche P; Pompilio G; Prosper F; Sena ES; Smart N; Zimmermann W-H; Fernandez-Aviles F. Insights into therapeutic products, preclinical research models and clinical trials in cardiac regenerative and reparative medicine: where are we now and the way ahead. Current opinion paper of the ESC working group on cardiovascular regenerative and reparative medicine. CARDIOVASCULAR RESEARCH Dec 01; 2020. DOI:10.1093/cvr/cvaa337. PMID:33258961. IF: 10,787

Guerra J.M., Vilahur G., Bayes de Luna A., Cabrera J.A., Martinez-Selles M., Mendieta G., Baranchuk A., Sanchez-Quintana D. (2020) Interatrial block can occur in the absence of left atrial enlargement: New experimental model. PACE, 43 (4), 427-429. IF: 1,9760

Kunadian V., Chieffo A., Camici P.G., Berry C., Escaned J., Maas A.H.E.M., Prescott E., Karam N., Appelman Y., Fraccaro C., Louise Buchanan G., Manzo-Silberman S., Al-Lamee R., Regar E., Lansky A., Abbott J.D., Badimon L., Duncker D.J., Mehran R., Capodanno D., Baumbach A. (2020) An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. EUR HEART J, 41 (37), 3504-3520. IF: 29,9830

Mach F., Baigent C., Catapano A.L., Koskinas K.C., Casula M., Badimon L., Chapman M.J., De Backer G.G., Delgado V., Ference B.A., Graham I.M., Halliday A., Landmesser U., Mihaylova B., Pedersen T.R., Riccardi G., Richter D.J., Sabatine M.S., Taskinen M.-R., Tokgozoglu L., Wiklund O. (2020) 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. EUR HEART J, 41 (1), 111-188. IF: 29,9830

Mach F, Baigent C, Catapano A, Koskinas K, Casula M, Badimon L, Chapman M, Guy G, Delgado V, Brian F, Graham I, Hallidayn A, Landmesser U, Mihaylovar B, Pedersent T, Riccardi G, Dimitrios R, Sabatine M, Taskinen M, et al. 2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk. ATHEROSCLEROSIS 1 Jan; 41(1); 111-188; 2020. DOI: 10.1093/eurheartj/ehz455. PMID:31504418. IF: 5,162

Manfrini O., Yoon J., van der Schaar M., Kedev S., Vavlukis M., Stankovic G., Scarpone M., Milicic D., Vasiljevic Z., Badimon L., Cenko E., Bugiardini R. (2020) Sex differences in modifiable risk factors and severity of coronary artery disease. J AM HEART ASSOC, 9 (19), e017235-. IF: 5,5010

Mendieta G., Ben-Aicha S., Gutierrez M., Casani L., Arzanauskaite M., Carreras F., Sabate M., Badimon L., Vilahur G., Intravenous Statin Administration During Myocardial Infarction Compared With Oral Post-Infarct Administration (2020) J AM COLL CARDIOL, 75 (12), 1386-1402. IF: 24,094

Mendieta G., Ben-Aicha S., Casani L., Badimon L., Sabate M., Vilahur G. (2020) Molecular pathways involved in the cardioprotective effects of intravenous statin administration during ischemia. BASIC RES CARDIOL, 115 (1), -. IF: 17,1650

Mendieta G., Ben-Aicha S., Gutierrez M., Casani L., Arzanauskaite M., Carreras F., Sabate M., Badimon L., Vilahur G. (2020) Intravenous Statin Administration During Myocardial Infarction Compared With Oral Post-Infarct Administration. J AM COLL CARDIOL, 75 (12), 1386-1402. IF: 24,0940

Padro T., Manfrini O., Bugiardini R., Canty J., Cenko E., De Luca G., Duncker D.J., Eringa E.C., Koller A., Tousoulis D., Trifunovic D., Vavlukis M., De Wit C., Badimon L. (2020) ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'. CARDIOVASC RES, 116 (4), 741-755. IF: 10,7870

Padro T; Munoz-Garcia N; Pena E; Badimon L. Sex differences and emerging new risk factors for atherosclerosis and its thrombotic complications. CURRENT PHARMACEUTICAL DESIGN Nov 17; 2020. DOI: 10.2174/1381612826666201118094209. PMID:33213315. IF: 3,116

Pedro-Botet J., Lopez-Miranda J., Badimon L., Civeira F., Guijarro C., Millan J., Mostaza J.M., Pinto X., Valdivielso P., Masana L. (2020) Overall Mortality and LDL Cholesterol Reduction in Secondary Prevention Trials of Cardiovascular Disease. AM J CARDIOVASC DRUG, 20 (4), 325-332. IF: 3,5710

Perez de Isla L., Arroyo-Olivares R., Alonso R., Muniz-Grijalvo O., Diaz-Diaz J.L., Zambon D., Fuentes F., Mata N., Piedecausa M., Manas M.D., Sanchez Munoz-Torrero J.F., Miramontes-Gonzalez J.P., De Andres R., Mauri M., Aguado R., Brea A., Cepeda J.M., Vidal-Pardo J.I., Martinez-Faedo C., Barba M.A., Argueso R., Ruiz-Perez E., Michan A., Arrieta F., Riestra Fernandez M., Perez L., Pinilla J.M., Diaz-Soto G., Pinto X., Padro T., Badimon L., Mata P., Perez-Corral B., Almagro F., Arroyo R., Isla L.P.D., Saltijeral A., Mosquera D., Casanas M., Carbayo J., Cepeda J.M., Diaz J.L., Dieguez M., Riestra M., Lopez-Miranda J., Galiana J., Garcia-Cruces J., Garrido J.A., Irigoyen L., Martinez P.L., Suarez L., Borrallo R.M., Mediavilla J.D., Jaen F., Gonzalez P., Rubio P., Miramontes P., Morera J.L., Muniz O., Gonzalez A., Pereyra F., Pastor J., Pinilla J.M., Romero M.J., Ruiz E., Alvarez M.P., Saenz P., Sanchez J.F., Sanz C., Vidal J.I. (2020) Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry Incidencia de eventos cardiovasculares y cambios en el riesgo estimado y en el tratamiento de la hipercolesterolemia familiar: registro SAFEHEART. REV ESP CARDIOL, 73 (10), 828-834. IF: 4,7530

Roldan Rabadan I., Esteve-Pastor M.A., Anguita Sanchez M., Muniz J., Ruiz Ortiz M., Marin F., Roldan V., Quesada M.A., Camacho Siles J., Cequier Fillat A., Bertomeu Martinez V., Martinez Selles M., Badimon L. (2020) Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study. EUR J INTERN MED, 78 (), 63-68. IF: 4,4870

Romero-Vazquez S., Adan A., Figueras-Roca M., Llorenc V., Slevin M., Vilahur G., Badimon L., Dick A.D., Molins B. (2020) Activation of C-reactive protein proinflammatory phenotype in the blood retinal barrier in vitro: Implications for age-related macular degeneration. AGING-US, 12 (14), 13905-13923. IF: 5,6820

Sanchez-Guijo F., Garcia-Olmo D., Prosper F., Martinez S., Zapata A., Fernandez-Aviles F., Toledo-Aral J.J., Torres M., Farinas I., Badimon L., Labandeira-Garcia J.L., Garcia-Sancho J., Moraleda J.M. (2020) Spanish Cell Therapy Network (TerCel): 15 years of successful collaborative translational research. CYTOTHERAPY, 22 (1), 1-5. IF: 5,4140

Sanz-Ruiz R, Janssens S, Pompilio G, Badimon L, Fernández-Avilés F. The ESC Working Group on cardiovascular regenerative and reparative medicine. EUROPEAN HEART JOURNAL Aug 1; 41(29):2721-2723; 2020. DOI: 10.1093/eurheartj/ehaa438. PMID:32738050. IF: 29,983

Silverman E.K., Schmidt H.H.H.W., Anastasiadou E., Altucci L., Angelini M., Badimon L., Balligand J.-L., Benincasa G., Capasso G., Conte F., Di Costanzo A., Farina L., Fiscon G., Gatto L., Gentili M., Loscalzo J., Marchese C., Napoli C., Paci P., Petti M., Quackenbush J., Tieri P., Viggiano D., Vilahur G., Glass K., Baumbach J. (2020) Molecular networks in Network Medicine: Development and applications. WIRES SYST BIOL MED, 12 (6), -. IF: 5,0000

Tanner FC, Brooks N, Fox KF, Gonçalves L, Kearney P, Michalis L, Pasquet A, Price S, Bonnefoy E, Westwood M, Plummer C, Kirchhof P; ESC Scientific Document Group. ESC Core Curriculum for the Cardiologist. EUROPEAN HEART JOURNAL Oct 7; 41(38):3605-3692; 2020. DOI: 10.1093/eurheartj/ehaa641. PMID:32862226. IF: 29,983

Vaccarino V., Badimon L., Bremner J.D., Cenko E., Cubedo J., Dorobantu M., Duncker D.J., Koller A., Manfrini O., Milicic D., Padro T., Pries A.R., Quyyumi A.A., Tousoulis D., Trifunovic D., Vasiljevic Z., de Wit C., Bugiardini R. (2020) Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation. EUR HEART J, 41 (17), 1687-1696. IF: 29,9830

Vilahur G., Arzanauskaite M., Sutelman P. (2020) Ticagrelor in Post-STEMI Adverse Ventricular Remodeling: There Is More Than Meets the Platelet. JACC-CARDIOVASC INTE, 13 (19), 2235-2237. IF: 11,1950

Wilemon K.A., Patel J., Aguilar-Salinas C., Ahmed C.D., Alkhnifsawi M., Almahmeed W., Alonso R., Al-Rasadi K., Badimon L., Bernal L.M., Bogsrud M.P., Braun L.T., Brunham L., Catapano A.L., Cillikova K., Corral P., Cuevas R., Defesche J.C., Descamps O.S., De Ferranti S., Eisele J.-L., Elikir G., Folco E., Freiberger T., Fuggetta F., Gaspar I.M., Gesztes A.G., Groselj U., Hamilton-Craig I., Hanauer-Mader G., Harada-Shiba M., Hastings G., Hovingh G.K., Izar M.C., Jamison A., Karlsson G.N., Kayikcioglu M., Koob S., Koseki M., Lane S., Lima-Martinez M.M., Lopez G., Martinez T.L., Marais D., Marion L., Mata P., Maurina I., Maxwell D., Mehta R., Mensah G.A., Miserez A.R., Neely D., Nicholls S.J., Nohara A., Nordestgaard Bo.G., Ose L., Pallidis A., Pang J., Payne J., Peterson A.L., Popescu M.P., Puri R., Ray K.K., Reda A., Sampietro T., Santos R.D., Schalkers I., Schreier L., Shapiro M.D., Sijbrands E., Soffer D., Stefanutti C., Stoll M., Sy R.G., Tamayo M.L., Tilney M.K., Tokgozoglu L., Tomlinson B., Vallejo-Vaz A.J., Vazquez-Cardenas A., De Luca P.V., Wald D.S., Watts G.F., Wenger N.K., Wolf M., Wood D., Zegerius A., Gaziano T.A., Gidding S.S. (2020) Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action. JAMA CARDIOL, 5 (2), 217-229. IF: 14,6760

Zamorano J.L., Gottfridsson C., Asteggiano R., Atar D., Badimon L., Bax J.J., Cardinale D., Cardone A., Feijen E.A.M., Ferdinandy P., Lopez-Fernandez T., Gale C.P., Maduro J.H., Moslehi J., Omland T., Plana Gomez J.C., Scott J., Suter T.M., Minotti G. (2020) The cancer patient and cardiology. EUR J HEART FAIL, 22 (12), 2290-2309. IF: 15,5340